{ "items": [ "\n\n
\n \n 17 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Bipin Adhikari, Research Physician in Social Sciences and Infectious Diseases at NDM\u2019s Mahidol Oxford Tropical Medicine Research Unit, has recently received the \u20182023 Emerging Leaders Award\u2019 from the Royal Society of Tropical Medicine and Hygiene in recognition of his leadership, service and significant contributions to the fields of tropical medicine and global health.
\n \n\n\n \n 13 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nThe ACT HIV trial conducted by NDM\u2019s Oxford University Clinical Research Unit (OUCRU), investigated the effectiveness of dexamethasone in reducing death, disability, and other complications in HIV-positive adults with tuberculous meningitis.
\n \n\n\n \n 12 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nA study, done as a part of a joint venture between Mexico\u2019s Cinvestav UGA-Langebio and NDM\u2019s Wellcome Centre for Human Genetics, has revealed an enormously rich tapestry of genetics revealing population histories and diverse genetic make-up of the Mexican population.
\n \n\n\n \n 10 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nToday Oxford University has launched a new global collaboration backed by \u00a38 million funding from UK Research and Innovation (UKRI). The project will be spearheaded by Professor Teresa Lambe, Professor of Vaccinology and Immunology and Calleva Head of Vaccine Immunology in the Department of Paediatrics and Professor Paul Klenerman, Sidney Truelove Professor of Gastroenterology and Director of the Translational Gastroenterology Unit at NDM, both of whom are Principal Investigators at NDM\u2019s Pandemic Sciences Institute.
\n \n\n\n \n 5 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Dame Sarah Gilbert, who became the Oxford Project Leader for the Oxford-AstraZeneca COVID-19 vaccine at the Nuffield Department of Medicine in 2020, has received the Freedom of the City of London, in recognition of her outstanding achievements in, and contribution to, science and public health.
\n \n\n\n \n 3 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nIn a study, recently published in the Cell, an international team of scientists, including CAMS Oxford Institute (COI) group leaders Professor Graham Ogg and Dr Yi-Ling Chen, has developed a method for simultaneously detecting thousands of lipid molecules that are displayed to T cells in the human immune system.
\n \n\n\n \n 2 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe World Health Organization\u2019s Strategic Advisory Group of Experts (SAGE) and Malaria Policy Advisory Group (MPAG) have recommended Oxford\u2019s R21/Matrix-M\u2122 malaria vaccine for use. The highly effective vaccine developed by the Jenner Institute and the Serum Institute of India has demonstrated high efficacy with a reassuring safety profile.
\n \n\n\n \n 29 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nFirst-ever direct comparison between the two leading COVID antivirals molnupiravir and nirmatrelvir (Paxlovid\u00ae), published in The Lancet Infectious Diseases by NDM's Mahidol Oxford Tropical Medicine Research Unit (MORU) researchers reported that, while both drugs worked, nirmatrelvir (Paxlovid\u00ae) was more effective, clearing the virus from the throat more rapidly than molnupiravir.
\n \n\n\n \n 28 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nA delegation from the Beijing Center for Disease Prevention and Control (Beijing CDC) visited the Chinese Academy of Medical Sciences Oxford Institute (COI) at NDM recently.
\n \n\n\n \n 22 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nIn a study, recently published in Genomics Medicine, researchers from NDM\u2019s Wellcome Centre for Human Genetics and the CAMS Oxford Institute investigated the long-term impact of COVID-19 on immune cells.
\n \n\n\n \n 18 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nA new clinical trial to find a vaccine to protect people against Middle East Respiratory Syndrome (MERS) launched on 15 September 2023. This is the third Phase I clinical trial of the ChAdOx1 MERS vaccine, developed by researchers at the Pandemic Sciences Institute. It is the first trial in older people.
\n \n\n\n \n 15 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers at the Pandemic Sciences Institute (PSI) are closely monitoring the current outbreak of deadly Nipah virus in Kerala, India. To date, there have been five confirmed cases and two deaths reported, with many of those affected being family members of the first patient. The Institute has collaborations with scientists involved in the response, including virologists at the National Institute of Virology in Pune.
\n \n\n\n \n 11 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nA University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time. CCHF is on the World Health Organization's top priority watchlist for viruses that could cause a future pandemic, and yet no approved vaccines currently exist.
\n \n\n\n \n 8 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nWe are delighted to announce that six researchers have been awarded the Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
\n \n\n\n \n 5 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nThree research teams from the University of Oxford, including those of Prof Frank von Delft, Professor for Structural Chemical Biology at NDM's Centre for Medicines Discovery and Dr Parinaz Mehdipour, Leadership Fellow at NDM\u2019s Ludwig Institute for Cancer Research, have been selected for the final stages of Cancer Grand Challenges.
\n \n\n\n \n 1 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n Department\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nOne year on from the launch of the Ling Felce Award for the training of researchers in Oxford, we reflect on the impact of the award and the generosity of our donors.
\n \n\n\n \n 31 August 2023\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nA study coordinated by NDM researchers published in BMC Medicine explores the factors predicting higher mortality in pregnant women with severe malaria and describes how severe falciparum malaria in pregnancy affects foetal health and mortality.
\n \n\n\n \n 30 August 2023\n \n
\n\n \n\n \n\n \n \n \n \n News\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.
\n \n\n\n \n 23 August 2023\n \n
\n\n \n\n \n\n \n \n \n \n Publications & research news\n \n \n\n \n\n\n
\n \n\n \n \n \nA new study published in The Lancet Global Health highlights the devastating impact of the COVID-19 pandemic on tuberculosis (TB) control in Indonesia, the nation with the second highest TB burden globally and the second highest burden of COVID-19 in the Asian region.
\n \n\n\n \n 22 August 2023\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nThe Society for Melanoma Research is devoted to alleviating the suffering of people with melanoma and was founded to unify the field by increasing communication among researchers and building bridges of collaboration between basic, translational, and clinical investigators.
\n \n\n